Literature DB >> 20718621

Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.

Emmanouil Papasavvas, Jihed Chehimi, Livio Azzoni, Maxwell Pistilli, Brian Thiel, Agnieszka Mackiewicz, Shenoa Creer, Karam Mounzer, Jay R Kostman, Luis J Montaner.   

Abstract

Mesh：

Year:  2010        PMID： 20718621      PMCID： PMC2982721          DOI： 10.1089/aid.2010.0020

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  15 in total

1.  Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Authors:  G M Ortiz; M Wellons; J Brancato; H T Vo; R L Zinn; D E Clarkson; K Van Loon; S Bonhoeffer; G D Miralles; D Montefiori; J A Bartlett; D F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.

Authors:  Jihed Chehimi; Donald E Campbell; Livio Azzoni; Darlene Bacheller; Emmanouil Papasavvas; Ghassen Jerandi; Karam Mounzer; Jay Kostman; Giorgio Trinchieri; Luis J Montaner
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

3.  Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.

Authors:  Annette Oxenius; David A Price; Huldrych F Günthard; Sara J Dawson; Catherine Fagard; Luc Perrin; Marek Fischer; Rainer Weber; Montserrat Plana; Felipe García; Bernard Hirschel; Angela McLean; Rodney E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

4.  Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters.

Authors:  Mark Dybul; Elizabeth Nies-Kraske; Marybeth Daucher; Kurt Hertogs; Claire W Hallahan; Gyorgy Csako; Christian Yoder; Linda Ehler; Peter A Sklar; Michael Belson; Bertha Hidalgo; Julia A Metcalf; Richard T Davey; Diane M Rock Kress; April Powers; Anthony S Fauci
Journal:  J Infect Dis       Date:  2003-07-10       Impact factor: 5.226

5.  Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.

Authors:  M Dybul; T W Chun; C Yoder; B Hidalgo; M Belson; K Hertogs; B Larder; R L Dewar; C H Fox; C W Hallahan; J S Justement; S A Migueles; J A Metcalf; R T Davey; M Daucher; P Pandya; M Baseler; D J Ward; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

6.  Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption.

Authors:  E Papasavvas; G M Ortiz; R Gross; J Sun; E C Moore; J J Heymann; M Moonis; J K Sandberg; L A Drohan; B Gallagher; J Shull; D F Nixon; J R Kostman; L J Montaner
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

7.  Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.

Authors:  H Donaghy; A Pozniak; B Gazzard; N Qazi; J Gilmour; F Gotch; S Patterson
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.

Authors:  Livio Azzoni; Emmanouil Papasavvas; Jihed Chehimi; Jay R Kostman; Karam Mounzer; Joe Ondercin; Bice Perussia; Luis J Montaner
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

9.  Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.

Authors:  Emmanouil Papasavvas; Maxwell Pistilli; Griffin Reynolds; Robert Bucki; Livio Azzoni; Jihed Chehimi; Paul A Janmey; Mark J DiNubile; Joe Ondercin; Jay R Kostman; Karam C Mounzer; Luis J Montaner
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

Review 10.  Lessons learned from HIV treatment interruption: safety, correlates of immune control, and drug sparing.

Authors:  Livio Azzoni; Emmanouil Papasavvas; Luis J Montaner
Journal:  Curr HIV Res       Date:  2003-07       Impact factor: 1.581
View more
  2 in total

1.  Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.

Authors:  Costin Tomescu; Domenico Mavilio; Luis J Montaner
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

2.  A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.

Authors:  Costin Tomescu; Qin Liu; Brian N Ross; Xiangfan Yin; Kenneth Lynn; Karam C Mounzer; Jay R Kostman; Luis J Montaner
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.